Medmira Stock Revenue
| MIR Stock | CAD 0.08 0.01 11.11% |
MedMira fundamentals help investors to digest information that contributes to MedMira's financial success or failures. It also enables traders to predict the movement of MedMira Stock. The fundamental analysis module provides a way to measure MedMira's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedMira stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 497.4 K | 472.5 K |
MedMira | Revenue |
MedMira Company Revenue Analysis
MedMira's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current MedMira Revenue | 432.53 K |
Most of MedMira's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedMira is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of MedMira
Projected quarterly revenue analysis of MedMira provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of MedMira match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in MedMira's stock price.
MedMira Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for MedMira is extremely important. It helps to project a fair market value of MedMira Stock properly, considering its historical fundamentals such as Revenue. Since MedMira's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MedMira's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MedMira's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
MedMira Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, MedMira reported 432.53 K of revenue. This is 99.99% lower than that of the Biotechnology sector and 99.94% lower than that of the Health Care industry. The revenue for all Canada stocks is 100.0% higher than that of the company.
MedMira Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedMira's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedMira could also be used in its relative valuation, which is a method of valuing MedMira by comparing valuation metrics of similar companies.MedMira is currently under evaluation in revenue category among its peers.
MedMira Current Valuation Drivers
We derive many important indicators used in calculating different scores of MedMira from analyzing MedMira's financial statements. These drivers represent accounts that assess MedMira's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of MedMira's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 276.5M | 79.0M | 88.5M | 62.8M | 56.5M | 33.0M | |
| Enterprise Value | 288.0M | 92.8M | 96.7M | 72.0M | 64.8M | 39.9M |
MedMira Fundamentals
| Return On Asset | -0.26 | ||||
| Operating Margin | (7.40) % | ||||
| Current Valuation | 65.59 M | ||||
| Shares Outstanding | 701.73 M | ||||
| Shares Owned By Insiders | 68.95 % | ||||
| Number Of Shares Shorted | 979 | ||||
| Price To Earning | (5.00) X | ||||
| Price To Sales | 146.45 X | ||||
| Revenue | 432.53 K | ||||
| Gross Profit | (512.51 K) | ||||
| EBITDA | (1.58 M) | ||||
| Net Income | (2.68 M) | ||||
| Cash And Equivalents | 1.06 K | ||||
| Total Debt | 9.27 M | ||||
| Current Ratio | 0.02 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (1.27 M) | ||||
| Short Ratio | 0.02 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | 10.73 | ||||
| Market Capitalization | 56.14 M | ||||
| Total Asset | 3.65 M | ||||
| Retained Earnings | (97.96 M) | ||||
| Working Capital | (14.03 M) | ||||
| Net Asset | 3.65 M |
About MedMira Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedMira's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedMira using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedMira based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.